Bristol-Myers Squibb: Make Lemonade From Lemons

Shareholders shouldn’t give up on Bristol-Myers Squibb just yet.

from WSJ.com: Markets http://ift.tt/2kxKGx9
via https://ifttt.com/ IFTTT